FR2372830A2 - Derives d'isoxazole, leur procede de preparation et leur application en therapeutique - Google Patents

Derives d'isoxazole, leur procede de preparation et leur application en therapeutique

Info

Publication number
FR2372830A2
FR2372830A2 FR7736547A FR7736547A FR2372830A2 FR 2372830 A2 FR2372830 A2 FR 2372830A2 FR 7736547 A FR7736547 A FR 7736547A FR 7736547 A FR7736547 A FR 7736547A FR 2372830 A2 FR2372830 A2 FR 2372830A2
Authority
FR
France
Prior art keywords
preparation process
therapeutic application
isoxazole derivatives
methylisoxazole
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7736547A
Other languages
English (en)
French (fr)
Other versions
FR2372830B2 (xx
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of FR2372830A2 publication Critical patent/FR2372830A2/fr
Application granted granted Critical
Publication of FR2372830B2 publication Critical patent/FR2372830B2/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7736547A 1976-12-04 1977-12-05 Derives d'isoxazole, leur procede de preparation et leur application en therapeutique Granted FR2372830A2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762655009 DE2655009A1 (de) 1976-12-04 1976-12-04 Isoxazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel

Publications (2)

Publication Number Publication Date
FR2372830A2 true FR2372830A2 (fr) 1978-06-30
FR2372830B2 FR2372830B2 (xx) 1980-06-20

Family

ID=5994666

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7736547A Granted FR2372830A2 (fr) 1976-12-04 1977-12-05 Derives d'isoxazole, leur procede de preparation et leur application en therapeutique

Country Status (13)

Country Link
JP (1) JPS5371070A (xx)
AT (1) AT362366B (xx)
BE (1) BE861503R (xx)
CA (1) CA1102341A (xx)
CH (1) CH608498A5 (xx)
DE (1) DE2655009A1 (xx)
DK (1) DK538677A (xx)
FR (1) FR2372830A2 (xx)
GB (1) GB1596383A (xx)
IE (1) IE46269B1 (xx)
IT (1) IT1126219B (xx)
LU (1) LU78628A1 (xx)
NL (1) NL7713151A (xx)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015173656A1 (en) * 2014-05-14 2015-11-19 Novartis Ag Carboxamide derivatives
WO2015175796A1 (en) * 2014-05-14 2015-11-19 Novartis Ag Carboxamide derivatives

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0035285A3 (en) * 1979-08-17 1981-10-14 American Cyanamid Company Novel isoxazole carboxylic acid phenyl esters, pharmaceutical compositions containing certain of said esters, and process for preparing said esters
JPS55500866A (xx) * 1978-11-03 1980-10-30
DE2854438A1 (de) * 1978-12-16 1980-07-03 Hoechst Ag Isoxazolderivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende mittel und ihre verwendung
DE3247454A1 (de) * 1982-12-22 1984-06-28 Laboratorios Bago S.A., Buenos Aires Substituierte 3-phenyl-5-methyl-isoxazol-4-carboxy-anilide, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
GB8619432D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds
GB8619433D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds
US4935434A (en) * 1988-01-26 1990-06-19 Bristol-Myers Company Antiarthritic isoxazole-4-carboxamides
IT1228288B (it) * 1989-01-09 1991-06-07 Zambon Spa Composti ad attivita' antiserotoninica
US5001124A (en) * 1990-02-02 1991-03-19 Syntex (U.S.A.) Inc. 4-isoxazolecarboxamide derivatives
DE59010701D1 (de) * 1990-05-18 1997-05-22 Hoechst Ag Isoxazol-4-carbonsäureamide und hydroxyalkyliden-cyanessigsäureamide, diese verbindungen enthaltende arzneimittel und deren verwendung
ZA913762B (en) 1990-05-18 1992-01-29 Hoechst Ag Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides,pharmaceuticals containing these compounds and their use
US7338956B2 (en) * 2002-08-07 2008-03-04 Sanofi-Aventis Deutschland Gmbh Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
CN103772376B (zh) * 2012-10-24 2017-01-11 中国医学科学院医药生物技术研究所 取代的苯并-1,3-杂唑类化合物、其制备方法及用途

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NV499/74 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015173656A1 (en) * 2014-05-14 2015-11-19 Novartis Ag Carboxamide derivatives
WO2015175796A1 (en) * 2014-05-14 2015-11-19 Novartis Ag Carboxamide derivatives
EA030938B1 (ru) * 2014-05-14 2018-10-31 Новартис Аг Производные карбоксамида
US11672782B2 (en) 2014-05-14 2023-06-13 Novartis Ag Carboxamide derivatives

Also Published As

Publication number Publication date
GB1596383A (en) 1981-08-26
CH608498A5 (en) 1979-01-15
JPS5371070A (en) 1978-06-24
IE46269B1 (en) 1983-04-20
ATA866377A (de) 1980-10-15
FR2372830B2 (xx) 1980-06-20
BE861503R (fr) 1978-06-05
AT362366B (de) 1981-05-11
CA1102341A (en) 1981-06-02
DE2655009A1 (de) 1978-06-15
NL7713151A (nl) 1978-06-06
LU78628A1 (xx) 1978-07-11
DE2655009C2 (xx) 1990-03-29
IT1126219B (it) 1986-05-14
IE46269L (en) 1978-06-04
DK538677A (da) 1978-06-05

Similar Documents

Publication Publication Date Title
FR2372830A2 (fr) Derives d'isoxazole, leur procede de preparation et leur application en therapeutique
FR2381028A1 (fr) Derives d'acide benzoique, leur procede de preparation et leur application en therapeutique
FR2313031A1 (fr) Derives d'anilides de l'acide cyanoacetique, leur procede de preparation et leur application
FR2395256A1 (fr) Derives de l'acide phenylacetique leurs procedes de preparation et leurs applications en therapeutique
FR2439182A1 (fr) Nouveaux derives cyclopeptidiques, leur preparation et leur application comme medicaments
BE827127A (fr) Nouveaux derives d'acide oxy-16 prostanoique, leur procede de preparation et leur utilisation therapeutique
FR2383157A1 (fr) Derives de chalcone, leur procede de preparation et leur application en therapeutique
FR2453158A1 (fr) Nouveaux acides benzimidazolyl-acetohydroxamiques, leur procede de preparation et leur application en therapeutique
FR2340735A1 (fr) Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament
FR2392971A1 (fr) Derives de l'acide prostanoique, leur preparation et medicament contenant ces substances
FR2400500A1 (fr) Derives d'acides cycloalcoylidenemethylphenylacetiques, leur procede de preparation et leur application en therapeutique
FR2421899A1 (fr) Nouveaux derives du tetrahydropyridinyl-indole et leurs sels, le procede de preparation et l'application a titre de medicaments de ces nouveaux produits
FR2453155A1 (fr) Derives de cyanoguanidine, leur procede de preparation et leurs applications en therapeutique
FR2281761A1 (fr) Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament
FR2415630A1 (fr) Nouvelles 5-vinyl-2-pyrrolidones, utiles notamment dans la preparation des acides 4-amino-5-hexenoique et 4-amino-5-hexynoique, et leur preparation
FR2445320A1 (fr) Derives de phenoxypyridine et leur procede de preparation
FR2422617A1 (fr) Derives polyprenyliques, leur procede de preparation et leur application en therapeutique
FR2443463A1 (fr) Derives de 4-aminoquinazoline, leur procede de preparation et leur application en agriculture, notamment comme fongicides
FR2400018A1 (fr) Nouveaux acides imidazolinylbenzoiques, leurs esters et leurs sels, leur procede de preparation et leur application comme insecticides
FR2442819A1 (fr) Alcools b,g-dihydropolyprenyliques, leur procede de preparation et leurs applications therapeutiques
FR2372836A1 (fr) Derives de l'acide propionique, leurs procedes de preparation et leur application en therapeutique
BE866911A (fr) Nouveaux derives d'amides de l'acide phenylacetique substitues, leur application en tant que medicament et leur preparation
BE845449A (fr) Amides d'acides 3-pyridyl-oxy-alcane-carboxyliques, leur procede de preparation et leur application a la regulation de la croissance des plantes
FR2357574A1 (fr) Nouveaux derives 16-acylthio de l'acide fusidique, utiles notamment comme antimicrobiens et leur procede de preparation
FR2456097A1 (fr) Nouveaux derives de la 5 h-furanone-2 et de la 3 h-dihydrofuranone-2, leur procede de preparation et leur application en therapeutique